While future studies are needed to determine whether the treatment-related gene sets outlined here play causal roles in resolving AD pathology, we note that the robust transcriptional changes induced by SCF+G-CSF treatment remarkably overlap with those in brain CD11b+ cells during a period of functional recovery in a mouse model of TDP-43 proteinopathy [147]. The gene discussed is CSF3; the disease is Alzheimer disease.